Literature DB >> 18330748

[Evoked potentials and regional cerebral blood flow changes in conversion disorder: a case report and review].

Nadide Gürses1, Cağri Mesut Temuçin, Eser Lay Ergün, Aygün Ertuğrul, Suzan Ozer, Başaran Demir.   

Abstract

Conversion disorder is defined as the presence of functional impairment in motor, sensory or neurovegetative systems which cannot be explained by a general medical condition. Although the diagnostic systems emphasize the absence of an organic basis for the dysfunction in conversion disorder, there has been a growing interest in the specific functional brain correlates of conversion symptoms in recent years, particularly by examining neuroimaging and neurophysiological measures. In this case report, regional cerebral blood flow changes and evoked potentials of a patient with conversion symptoms are presented. Somatosensory evoked potentials (SEP) of this patient with conversion disorder who had signs of movement disorder revealed that the latency to N20, P 25 waves were in normal limits while the amplitudes of the P25 and N33 components were extremely high (giant SEP). Regional cerebral blood flow assessment revealed hypoperfusion in the left parietal and temporal lobes of the brain. Three months after the first assessment, the control scans showed that the left parietal hypoperfusion disappeared while the left temporal hypoperfusion was still present. The following SEP evaluations which were repeated twice in three months intervals after the initial recordings, showed the persistence of the abnormalities in somatosensorial measures. The neurophysiological and neuroimaging findings in conversion disorder were reviewed and the results of the evaluations of this case were discussed in this article.

Entities:  

Mesh:

Year:  2008        PMID: 18330748

Source DB:  PubMed          Journal:  Turk Psikiyatri Derg        ISSN: 1300-2163


  3 in total

1.  Significance and clinical suggestions for the somatosensory evoked potentials increased in amplitude revealed by a large sample of neurological patients.

Authors:  Davide Rossi Sebastiano; Daniele Cazzato; Elisa Visani; Eleonora Dalla Bella; Laura Brambilla; Grazia Devigili; Paola Caroppo; Lorenzo Maggi; Lorenzo Nanetti; Ettore Salsano; Laura Canafoglia; Isabella Canavero; Elena Anghileri; Deborah Bonfoco; Paola Lanteri
Journal:  Neurol Sci       Date:  2022-06-27       Impact factor: 3.830

2.  Functional Neurological Symptom Disorder: A Diagnostic Algorithm.

Authors:  Eugénie Girouard; Isabelle Savoie; Ludivine Chamard Witkowski
Journal:  Behav Neurol       Date:  2019-07-25       Impact factor: 3.342

3.  Assessment of cytokines, microRNA and patient related outcome measures in conversion disorder/functional neurological disorder (CD/FND): The CANDO clinical feasibility study.

Authors:  Christina van der Feltz-Cornelis; Sally Brabyn; Jonathan Ratcliff; Danielle Varley; Victoria Allgar; Simon Gilbody; Chris Clarke; Dimitris Lagos
Journal:  Brain Behav Immun Health       Date:  2021-02-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.